Joel Greenblatt acquired 72.5k Veracyte shares worth $3.62M. That's 0.01% of their equity portfolio (941st largest holding). The first Veracyte trade was made in Q2 2019. Since then Joel Greenblatt bought shares eleven more times and sold shares on ten occasions. The stake costed the investor $2.07M, netting the investor a gain of 75% so far.